Related Experiment Video
Updated: Mar 24, 2026
03:40
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
1.7K
Advances in Understanding and Managing Chronic Urticaria
Yasmin Moolani1, Charles Lynde2, Gordon Sussman3
1Division of Clinical Immunology and Allergy, University of Toronto, Toronto, OH, Canada.
F1000Research
|March 8, 2016
Summary
Recent advances update chronic urticaria classification, replacing older terms with chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CINDU). Guidelines now emphasize evidence-based treatments like H1 antihistamines and omalizumab.
Area of Science:
- Allergy and Immunology
- Dermatology
- Clinical Medicine
Background:
- Chronic urticaria classification has evolved, with new terms like chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CINDU) replacing older terminology.
- Recent guideline revisions by major allergy and dermatology organizations reflect a new understanding of chronic urticaria.
- Existing treatment options often lacked strong evidence, necessitating an update in management strategies.
Purpose of the Study:
- To summarize recent advances in the classification and management of chronic urticaria.
- To highlight the updated terminology and revised treatment guidelines.
- To discuss the evidence-based therapeutic options, including antihistamines and omalizumab.
Main Methods:
- Review of recent scientific literature and guideline updates from key organizations like AAAAI and EAACI/GA(2)LEN/EDF/WAO.
- Analysis of the new classification system for chronic urticaria.
- Evaluation of the efficacy and safety data for recommended treatments.
Main Results:
- Chronic urticaria is now classified into chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CINDU).
- First-line treatment involves H1 antihistamines, with options for dose escalation.
- Omalizumab is established as a safe and effective third-line treatment for CSU and shows promise for CINDU.
Conclusions:
- The management of chronic urticaria is becoming more simplified and evidence-based.
- Updated guidelines provide a clearer treatment algorithm with more effective and safer options.
- Omalizumab represents a significant therapeutic advance in treating chronic urticaria.
Related Concept Videos
01:30Hypersensitivities
8.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
8.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
01:20Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
01:30Asthma-IV: Nursing Management
4.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
4.0K
01:29Chronic Pancreatitis II: Collaborative Care
471
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
471